MD Ehlers

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
For many neurological and psychiatric diseases, novel therapeutics have been elusive for decades. By focusing on attention interference in Alzheimer's disease (AD), we provide a future vision on how emerging mobile, computer, and device-based cognitive tools are converting classically noisy, subjective, data-poor clinical endpoints associated with(More)
  • 1